𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatorenal syndrome without avid sodium retention

✍ Scribed by Francis J. Dudley; Gary C. Kanel; Laurence J. Wood; Telfer B. Reynolds


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
509 KB
Volume
6
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


A urinary sodium concentration [U(Na)] of less than 10 mmoles per liter is considered important in differentiating hepatorenal syndrome from other causes of progressive renal impairment in patients with liver disease. However, occasionally, patients with hepatorenal syndrome have been recognized in whom the U(Na) is consistently greater than 10 mmoles per liter. Eight such patients, in all of whom there was no clinical or laboratory evidence to implicate other causes of progressive renal impairment, were identified. The clinical features, hepatic and renal status and hospital course were compared with eight other patients who had hepatorenal syndrome and a U(Na) consistently less than 10 mmoles per liter. The mean U(Na) was 24 +/- 4 mmoles per liter in the high U(Na) group and 3.7 +/- 1.8 mmoles per liter in the low U(Na) group. All patients in both groups had acutely decompensated alcoholic hepatitis of similar severity and activity. The high U(Na) group had significantly less clinical ascites and peripheral edema and higher serum levels of sodium and chloride both at the onset of the hepatorenal syndrome and throughout the clinical course. Significant differences in the serum potassium and blood urea nitrogen levels became apparent between the two groups of patients as renal failure progressed, and the mean average blood urea nitrogen to serum creatinine ratio was significantly higher (p less than 0.025) in the low U(Na) group (13.8 +/- 0.9 vs. 10.1 +/- 1.1). Mean urinary potassium concentration was significantly higher in the high U(Na) patients but urinary creatinine concentrations, specific gravity and sediment were similar in both groups of patients.(ABSTRACT TRUNCATED AT 250 WORDS)


πŸ“œ SIMILAR VOLUMES


Terlipressin improves renal function in
✍ Aleksander Krag; SΓΈren MΓΈller; Jens H. Henriksen; Niels-Henrik Holstein-Rathlou; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 1 views

Patients with advanced cirrhosis and ascites are characterized by circulatory dysfunction with splanchnic vasodilatation and renal vasoconstriction, which often lead to ascites. The vasoconstrictor terlipressin improves renal function in hepatorenal syndrome (HRS). The aim of this study was to evalu

Effects of amiloride on renal lithium ha
✍ Paolo Angeli; Erica De Bei; Manuela Dalla Pria; Lorenza Caregaro; Giulio Ceolott πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 466 KB πŸ‘ 2 views

The reliability of lithium clearance as an index of distal fluid delivery in cirrhosis with ascites and in other clinical conditions characterized by low fractional sodium excretion has not yet been proven. In particular, lithium reabsorption in the amiloridesensitive segment of the distal tubule, a

Blunted natriuretic response to low-dose
✍ Giorgio La Villa; Donato Riccardi; Chiara Lazzeri; Vincenzo Casini Raggi; Antoni πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 646 KB

Patients with cirrhosis and ascites have high plasma levels of atrial (AN") and brain (BNP) natriuretic peptides, two cardiac hormones released by the atria and ventricles, respectively. We evaluated renal hemodynamics, sodium excretion, and intrarenal sodium handling (lithium clearance method) in s